Use of nucleoside (tide) analogues in patients with hepatitis B-related acute liver failure

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

  • Doan Y Dao
  • Emmanuel Seremba
  • Veeral Ajmera
  • Corron Sanders
  • Linda S Hynan
  • William M Lee
  • Acute Liver Failure Study Group
  • Schiødt, Frank Vinholt
The efficacy of nucleoside(tide) analogues (NA) in the treatment of acute liver failure due to hepatitis B virus (HBV-ALF) remains controversial. We determined retrospectively the impact of NAs in a large cohort of patients with HBV-ALF.
OriginalsprogEngelsk
TidsskriftDigestive Diseases and Sciences
Vol/bind57
Udgave nummer5
Sider (fra-til)1349-57
Antal sider9
ISSN0163-2116
DOI
StatusUdgivet - 2012

ID: 48566106